A man purporting to be one of the Taliban's most senior commanders convinced both Afghan President Hamid Karzai and the NATO officials who flew him to Afghanistan's capital for meetings, but two senior Afghan officials now believe the man was a lowly shopkeeper from the Pakistani city of Quetta.
His daring ruse has flummoxed those attempting to start a peace process with a determined Taliban adversary. "He was a very clever man," one of the officials said.
		



A majority of Americans want the Congress to keep the new health care law or actually expand it, despite Republican claims that they have a mandate from the people to kill it, according to a new McClatchy-Marist poll.
Former Attorney General Alberto Gonzales told TPM in an exclusive interview that he was aware of the so-called enhanced interrogation techniques used against suspected terrorists like Khalid Sheikh Mohammed.
WikiLeaks' next release will be seven times the size of the Iraq war logs, already the biggest leak in U.S. intelligence history, the website said Monday.
Israel's parliament has passed a bill setting stringent new conditions before any withdrawal from the Golan Heights or East Jerusalem.
On September 24th, the FBI raided the homes of 14 peace activists in Minneapolis and Chicago, ostensibly searching for possible "material support" to terrorist organizations.
For only the second time, the Food and Drug Administration approved a company's request to test an embryonic stem cell-based therapy on human patients. Advanced Cell Technology (ACT), based in Marlborough, Mass., will begin testing its retinal cell treatment this year in a dozen patients with Stargardt's macular dystrophy, an inherited degenerative eye disease that leads to blindness in children. In July, the FDA released its hold on the first trial of an embryonic stem cell based treatment, for spinal cord injury.





























